Mastrapasqua Asset Management »

SPDR S&P Biotech shares owned by Mastrapasqua Asset Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Mastrapasqua Asset Management from 13F filings

Historical chart of Mastrapasqua Asset Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Mastrapasqua Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Mastrapasqua Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $206k 2.8k 73.02
2023-06-30 $207k 2.5k 83.20

More positions owned by Mastrapasqua Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Visa Com Cl A (V)
Thermo Fisher Scientific (TMO)
Costco Wholesale Corporation (COST)
Marsh & McLennan Companies (MMC)
Zoetis Cl A (ZTS)
Home Depot (HD)
Amgen (AMGN)

View all positions for Mastrapasqua Asset Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities
Brown Advisory Holdings Incorporated

View all funds holding SPDR S&P Biotech